DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 26, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here:

Frequently Asked Questions regarding this change may be found here: Hydrocodone FAQs

More Latest News

DEA Warns Public of Extortion Scam by DEA Special Agent Impersonators
January 29, 2018

The Drug Enforcement Administration is warning the public about criminals posing as DEA Special Agents or other law enforcement personnel as part of an international extortion scheme. Continue reading

Updated Florida Medical Marijuana Course for MMTC Medical Directors
January 16, 2018

Attention Physicians: If you plan to continue to be a Medical Director for a Florida MMTC, click here for more information. Continue reading